Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sulphasalazine-induced lupus syndrome in ulcerative colitis.

Literature DB >> 22375

Sulphasalazine-induced lupus syndrome in ulcerative colitis.

I D Griffiths, S P Kane.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Sulfasalazine

Year: 1977 PMID： 22375 PMCID： PMC1632158 DOI： 10.1136/bmj.2.6096.1188

Source DB: PubMed Journal: Br Med J ISSN： 0007-1447

× No keyword cloud information.

8 in total

Review 1. The major histocompatibility complex - genetics and biology (third of three parts).

Authors: F H Bach; J J van Rood
Journal: N Engl J Med Date: 1976-10-21 Impact factor: 91.245

2. The relation between heart and joint disease including "rheumatoid heart disease" and chronic post rheumatic arthritis (type Jaccoud).

Authors: E G L BYWATERS
Journal: Br Heart J Date: 1950-04

3. Antinuclear factor in rapid and slow acetylator patients treated with isoniazid.

Authors: D A Evans; M F Bullen; J Houston; C A Hopkins; J M Vetters
Journal: J Med Genet Date: 1972-03 Impact factor: 6.318

4. Immunologic factors and clinical activity in systemic lupus erythematosus.

Authors: P H Schur; J Sandson
Journal: N Engl J Med Date: 1968-03-07 Impact factor: 91.245

5. Serum immune complexes and disease activity in lupus nephritis.

Authors: R J Levinsky; J S Cameron; J F Soothill
Journal: Lancet Date: 1977-03-12 Impact factor: 79.321

6. Human anti-DNA antibody: reference standards for diagnosis and management of systemic lupus erythematosus.

Authors: J Holian; I D Griffiths; D N Glass; R N Maini; J T Scott
Journal: Ann Rheum Dis Date: 1975-10 Impact factor: 19.103

7. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q.

Authors: U E Nydegger; P H Lambert; H Gerber; P A Miescher
Journal: J Clin Invest Date: 1974-08 Impact factor: 14.808

8. The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.

Authors: K M Das; M A Eastwood; J P McManus; W Sircus
Journal: Gut Date: 1973-08 Impact factor: 23.059

8 in total

13 in total

1. Hypersensitivity reaction to balsalazide.

Authors: V Adhiyaman; A Vaishnavi; S Froese
Journal: BMJ Date: 2000-03-04

2. Drug points: Hypersensitivity reaction to balsalazide.

Authors: V Adhiyaman; A Vaishnavi; S Froese
Journal: BMJ Date: 2001-09-01

3. Sulphasalazine-induced systemic lupus erythematous in a patient with ankylosing spondylitis.

Authors: W C Tsai; C J Chen; J H Yen; H W Liu
Journal: Clin Rheumatol Date: 2002-08 Impact factor: 2.980

Review 4. Sulfasalazine. Adverse effects and desensitization.

Authors: S L Taffet; K M Das
Journal: Dig Dis Sci Date: 1983-09 Impact factor: 3.199

5. Sulphasalazine-induced cerebral lupus erythematosus.

Authors: P Rafferty; A C Young; M R Haeney
Journal: Postgrad Med J Date: 1982-02 Impact factor: 2.401

6. Antibodies to the five histones and poly(adenosine diphosphate-ribose) in drug induced lupus: implications for pathogenesis.

Authors: R N Hobbs; A L Clayton; R M Bernstein
Journal: Ann Rheum Dis Date: 1987-05 Impact factor: 19.103